GO
Loading...

AstraZeneca rejects Pfizer's deal: Is it the end?

Monday, 19 May 2014 | 4:00 AM ET

Mick Cooper, health care analyst at Edison Investment Research, says that AstraZeneca is under a lot of pressure to deliver after it rejected Pfizer - which could come back in another six months.